TY - JOUR
T1 - Caffeine intake enhances peak oxygen uptake and performance during high-intensity cycling exercise in moderate hypoxia
AU - Lei, Tze Huan
AU - Qin, Qiyang
AU - Girard, Olivier
AU - Mündel, Toby
AU - Wang, Ran
AU - Guo, Li
AU - Cao, Yinhang
PY - 2024/2
Y1 - 2024/2
N2 - Purpose: We investigated whether caffeine consumption can enhance peak oxygen uptake (V ˙ O 2peak) by increasing peak ventilation during an incremental cycling test, and subsequently enhance time to exhaustion (TTE) during high-intensity cycling exercise in moderate normobaric hypoxia. Methods: We conducted a double-blind, placebo cross-over design study. Sixteen recreational male endurance athletes (age: 20 ± 2 years, V ˙ O 2peak : 55.6 ± 3.6 ml/kg/min, peak power output: 318 ± 40 W) underwent an incremental cycling test and a TTE test at 80% V ˙ O 2peak (derived from the placebo trial) in moderate normobaric hypoxia (fraction of inspired O2: 15.3 ± 0.2% corresponding to a simulated altitude of ~ 2500 m) after consuming either a moderate dose of caffeine (6 mg/kg) or a placebo. Results: Caffeine consumption resulted in a higher peak ventilation [159 ± 21 vs. 150 ± 26 L/min; P < 0.05; effect size (ES) = 0.31]. V ˙ O 2peak (3.58 ± 0.44 vs. 3.47 ± 0.47 L/min; P < 0.01; ES = 0.44) and peak power output (308 ± 44 vs. 302 ± 44 W; P = 0.02, ES = 0.14) were higher following caffeine consumption than during the placebo trial. During the TTE test, caffeine consumption enhanced minute ventilation (P = 0.02; ES = 0.28) and extended the TTE (426 ± 74 vs. 358 ± 75 s; P < 0.01, ES = 0.91) compared to the placebo trial. There was a positive correlation between the percent increase of V ˙ O 2peak following caffeine consumption and the percent increase in TTE (r = 0.49, P < 0.05). Conclusion: Moderate caffeine consumption stimulates breathing and aerobic metabolism, resulting in improved performance during incremental and high-intensity endurance exercises in moderate normobaric hypoxia.
AB - Purpose: We investigated whether caffeine consumption can enhance peak oxygen uptake (V ˙ O 2peak) by increasing peak ventilation during an incremental cycling test, and subsequently enhance time to exhaustion (TTE) during high-intensity cycling exercise in moderate normobaric hypoxia. Methods: We conducted a double-blind, placebo cross-over design study. Sixteen recreational male endurance athletes (age: 20 ± 2 years, V ˙ O 2peak : 55.6 ± 3.6 ml/kg/min, peak power output: 318 ± 40 W) underwent an incremental cycling test and a TTE test at 80% V ˙ O 2peak (derived from the placebo trial) in moderate normobaric hypoxia (fraction of inspired O2: 15.3 ± 0.2% corresponding to a simulated altitude of ~ 2500 m) after consuming either a moderate dose of caffeine (6 mg/kg) or a placebo. Results: Caffeine consumption resulted in a higher peak ventilation [159 ± 21 vs. 150 ± 26 L/min; P < 0.05; effect size (ES) = 0.31]. V ˙ O 2peak (3.58 ± 0.44 vs. 3.47 ± 0.47 L/min; P < 0.01; ES = 0.44) and peak power output (308 ± 44 vs. 302 ± 44 W; P = 0.02, ES = 0.14) were higher following caffeine consumption than during the placebo trial. During the TTE test, caffeine consumption enhanced minute ventilation (P = 0.02; ES = 0.28) and extended the TTE (426 ± 74 vs. 358 ± 75 s; P < 0.01, ES = 0.91) compared to the placebo trial. There was a positive correlation between the percent increase of V ˙ O 2peak following caffeine consumption and the percent increase in TTE (r = 0.49, P < 0.05). Conclusion: Moderate caffeine consumption stimulates breathing and aerobic metabolism, resulting in improved performance during incremental and high-intensity endurance exercises in moderate normobaric hypoxia.
KW - Ergogenic aid
KW - Exercise capacity
KW - Exhaustion
KW - Hypoxia exposure
KW - Incremental exercise
KW - Ventilation
UR - http://www.scopus.com/inward/record.url?scp=85168609645&partnerID=8YFLogxK
U2 - 10.1007/s00421-023-05295-0
DO - 10.1007/s00421-023-05295-0
M3 - Article
C2 - 37608124
AN - SCOPUS:85168609645
SN - 1439-6319
VL - 124
SP - 537
EP - 549
JO - European Journal of Applied Physiology
JF - European Journal of Applied Physiology
IS - 2
ER -